BioMarin Pharmaceuticals
BMRN
BMRN
485 hedge funds and large institutions have $15.9B invested in BioMarin Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 202 increasing their positions, 159 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.69% less ownership
Funds ownership: 100.77% → 100.09% (-0.69%)
29% less call options, than puts
Call options by funds: $102M | Put options by funds: $144M
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
Holders
485
Holding in Top 10
7
Calls
$102M
Puts
$144M
Top Buyers
| 1 | +$72.1M | |
| 2 | +$65.6M | |
| 3 | +$49.4M | |
| 4 |
ClearBridge Investments
New York
|
+$44.4M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$43.9M |
Top Sellers
| 1 | -$145M | |
| 2 | -$81.3M | |
| 3 | -$59.7M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$49.3M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$29.9M |